Chemical and Allied Products Plc (NGX: CAP)
Nigeria
· Delayed Price · Currency is NGN
47.00
-0.75 (-1.57%)
At close: Jan 29, 2025
NGX: CAP Balance Sheet
Financials in millions NGN. Fiscal year is January - December.
Millions NGN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 7,015 | 7,015 | 4,996 | 3,761 | 2,572 | 5,748 | Upgrade
|
Cash & Short-Term Investments | 7,015 | 7,015 | 4,996 | 3,761 | 2,572 | 5,748 | Upgrade
|
Cash Growth | 40.40% | 40.40% | 32.85% | 46.23% | -55.26% | 32.97% | Upgrade
|
Accounts Receivable | 1,190 | 1,190 | 624.57 | 579.36 | 483.78 | 410.07 | Upgrade
|
Other Receivables | - | - | 129.28 | 175.52 | 29.99 | 14.58 | Upgrade
|
Receivables | 1,190 | 1,190 | 753.84 | 754.88 | 513.77 | 424.65 | Upgrade
|
Inventory | 6,426 | 6,426 | 5,020 | 5,101 | 5,484 | 988.3 | Upgrade
|
Prepaid Expenses | 1,232 | 1,232 | 84.93 | 78.41 | - | - | Upgrade
|
Other Current Assets | 190.84 | 190.84 | 2,183 | 1,571 | 1,947 | 500.45 | Upgrade
|
Total Current Assets | 16,053 | 16,053 | 13,038 | 11,266 | 10,517 | 7,662 | Upgrade
|
Property, Plant & Equipment | 3,253 | 3,253 | 1,998 | 1,735 | 1,392 | 851.33 | Upgrade
|
Other Intangible Assets | 266.48 | 266.48 | 327.65 | 394.82 | 196.93 | 4.21 | Upgrade
|
Long-Term Accounts Receivable | 10.37 | 10.37 | 10.37 | 10.37 | 10.37 | 8.77 | Upgrade
|
Total Assets | 19,583 | 19,583 | 15,374 | 13,406 | 12,116 | 8,526 | Upgrade
|
Accounts Payable | 4,922 | 4,922 | 1,460 | 990.34 | 3,855 | 627.83 | Upgrade
|
Accrued Expenses | - | - | 2,210 | 2,111 | 1,737 | 1,071 | Upgrade
|
Short-Term Debt | - | - | 39.83 | 735.11 | 6.17 | 75.1 | Upgrade
|
Current Portion of Leases | - | - | - | 1.42 | 1.42 | 1.31 | Upgrade
|
Current Income Taxes Payable | 1,970 | 1,970 | 1,122 | 922.8 | 536.13 | 589.84 | Upgrade
|
Other Current Liabilities | 1,524 | 1,524 | 2,075 | 1,710 | 1,397 | 2,251 | Upgrade
|
Total Current Liabilities | 8,416 | 8,416 | 6,907 | 6,470 | 7,532 | 4,616 | Upgrade
|
Long-Term Leases | 7.96 | 7.96 | 7.96 | 7.87 | 7.87 | 7.88 | Upgrade
|
Long-Term Deferred Tax Liabilities | 489.09 | 489.09 | 489.09 | 328.67 | 165.81 | 157.66 | Upgrade
|
Total Liabilities | 8,913 | 8,913 | 7,404 | 6,807 | 7,706 | 4,781 | Upgrade
|
Common Stock | 407.37 | 407.37 | 407.37 | 407.37 | 394.13 | 350 | Upgrade
|
Additional Paid-In Capital | 523.85 | 523.85 | 523.85 | 523.85 | 19.25 | 19.25 | Upgrade
|
Retained Earnings | 8,770 | 8,770 | 6,070 | 4,700 | 3,028 | 3,376 | Upgrade
|
Comprehensive Income & Other | 968.27 | 968.27 | 968.27 | 968.27 | 968.27 | - | Upgrade
|
Shareholders' Equity | 10,670 | 10,670 | 7,970 | 6,600 | 4,410 | 3,745 | Upgrade
|
Total Liabilities & Equity | 19,583 | 19,583 | 15,374 | 13,406 | 12,116 | 8,526 | Upgrade
|
Total Debt | 7.96 | 7.96 | 47.79 | 744.4 | 15.46 | 84.29 | Upgrade
|
Net Cash (Debt) | 7,007 | 7,007 | 4,949 | 3,017 | 2,557 | 5,664 | Upgrade
|
Net Cash Growth | 41.59% | 41.59% | 64.04% | 18.00% | -54.86% | 31.21% | Upgrade
|
Net Cash Per Share | 8.59 | 8.59 | 6.00 | 3.70 | 3.24 | 8.09 | Upgrade
|
Filing Date Shares Outstanding | 813.02 | 813.02 | 814.75 | 814.75 | 788.26 | 700 | Upgrade
|
Total Common Shares Outstanding | 813.02 | 813.02 | 814.75 | 814.75 | 788.26 | 700 | Upgrade
|
Working Capital | 7,637 | 7,637 | 6,131 | 4,796 | 2,984 | 3,046 | Upgrade
|
Book Value Per Share | 13.12 | 13.12 | 9.78 | 8.10 | 5.59 | 5.35 | Upgrade
|
Tangible Book Value | 10,403 | 10,403 | 7,642 | 6,205 | 4,213 | 3,741 | Upgrade
|
Tangible Book Value Per Share | 12.80 | 12.80 | 9.38 | 7.62 | 5.34 | 5.34 | Upgrade
|
Land | - | - | 1.41 | 1.41 | 1.41 | 1.41 | Upgrade
|
Buildings | - | - | 206.9 | 157.86 | 146.14 | 72.64 | Upgrade
|
Machinery | - | - | 4,085 | 3,611 | 2,926 | 1,645 | Upgrade
|
Construction In Progress | - | - | - | 2.81 | - | 6.71 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.